Protagonist Therapeutics, Inc - COM (PTGX)

Historical Portfolio Holders from Q3 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
61.7M
Holdings value Q3 2024
$2.78B
Value change Q3 2024
-$36.7M
Grand Portfolio weight change Q3 2024
0%
Number of holders
237
Number of buys Q3 2024
151
Number of sells Q3 2024
-87
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 61.7M $2.78B -$36.7M $45.00 238
2024 Q2 59.1M $2.05B -$21.7M $34.65 189
2024 Q1 59.9M $1.73B +$85.9M $28.93 182
2023 Q4 57.5M $1.32B +$12.2M $22.93 155
2023 Q3 56.7M $946M -$53.3M $16.68 142
2023 Q2 56.7M $1.57B +$105M $27.62 167
2023 Q1 53.2M $1.22B +$180M $23.00 139
2022 Q4 48.9M $533M +$12.5M $10.91 135
2022 Q3 47.2M $398M -$51.2M $8.43 129
2022 Q2 53.4M $422M -$73.7M $7.91 131
2022 Q1 50.3M $1.19B -$6.17M $23.68 140
2021 Q4 49.2M $1.68B +$93.5M $34.20 148
2021 Q3 46.2M $819M -$247M $17.72 127
2021 Q2 48M $2.15B +$180M $44.88 136
2021 Q1 44.2M $1.14B +$27.8M $25.90 124
2020 Q4 43M $867M +$98.8M $20.16 124
2020 Q3 37.2M $727M +$62.1M $19.55 91
2020 Q2 34M $601M +$210M $17.66 82
2020 Q1 23.4M $165M +$1.23M $7.06 75
2019 Q4 23.2M $164M +$7.87M $7.05 79
2019 Q3 18.9M $228M +$20.6M $12.01 74
2019 Q2 17.2M $208M +$26M $12.11 66
2019 Q1 15.1M $189M +$21.7M $12.57 64
2018 Q4 13.9M $93.2M -$9.99M $6.73 62
2018 Q3 16M $165M +$26.8M $10.29 60
2018 Q2 13.9M $93.6M +$10.9M $6.72 68
2018 Q1 11.9M $103M -$12M $8.59 67
2017 Q4 11.8M $246M +$77.2M $20.80 64
2017 Q3 8.13M $144M +$553K $17.67 41
2017 Q2 8.11M $91.8M -$283K $11.31 39
2017 Q1 8.01M $103M +$4.47M $12.81 39
2016 Q4 7.98M $175M +$2.37M $21.99 38
2016 Q3 6.9M $145M +$145M $21.13 34